Arbour Group Expands Its Regulatory Compliance Footprint in Research Triangle Park

RALEIGH, N.C. and DURHAM, N.C., July 22, 2019 /PRNewswire/ — Arbour Group LLC, a global provider of regulatory compliance services for the life sciences industry, has named industry executive Dominic Mancini as their new Vice President of Business Development. Dominic brings 16 plus years of experience in the biotech, pharma and medtech industries. His expertise expands across clinical services, product development and R&D intelligence, creating a vast network of service-oriented client relationships.

Mancini will be responsible for building Arbour’s footprint in the Raleigh-Durham biotech, pharma and medtech communities and beyond into the broader southeast market. “North Carolina is home to many emerging life science R&D innovators, pharmaceutical manufacturers, medical device and contract research organizations,” Mancini notes. “With over 20 years of global compliance experience, exceptional delivery performance and outstanding customer service, Arbour Group is prepared to support this region’s evolving life science software technology systems toward compliance with all applicable regulations.”

“I’m excited for Dominic to join the Arbour team,” said Ahsan Raza, President of Arbour Group. “His integrated business development, sales experience and scalable marketing methods will help us capitalize on the strength of Arbour products and services.” Arbour Group will be opening a Raleigh-Durham office to be located at the North Carolina Biotechnology Center in the Research Triangle Park. With Dominic’s local presence, this move will mark a notable presence for Arbour Group in support of planned growth strategies in NC.

Media Contact: Angelica Perez 3122075816 aperez@arbourgroup.com

Related Links

Arbour Group RTP Office

Contact Arbour Group

View original content:http://www.prnewswire.com/news-releases/arbour-group-expands-its-regulatory-compliance-footprint-in-research-triangle-park-300888359.html

SOURCE Arbour Group

Staff

Recent Posts

Cantargia Reports Progress Towards Start of DOD-Sponsored Clinical Trial of Nadunolimab in Leukemia

LUND, SWEDEN / ACCESSWIRE / March 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq…

2 hours ago

RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting

Relief Therapeutics Calls Extraordinary General Meeting Anticipated Board of Directors OverhaulGENEVA, SWITZERLAND / ACCESSWIRE /…

2 hours ago

PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease

Pivotal Trial for Improving Overall Function and Quality of LifeSALT LAKE CITY--(BUSINESS WIRE)--#medicaldevices--PhotoPharmics, a pioneer…

11 hours ago

AARC Celebrates Introduction of the SOAR Act in the House of Representatives

Bill passage key to supplemental oxygen access and adequate reimbursementIRVING, TX / ACCESSWIRE / March…

14 hours ago

She Is Not Skipping a Beat, and Patients Are Noticing

NORTHAMPTON, MA / ACCESSWIRE / March 26, 2024 / Quest Diagnostics At Quest for 2…

14 hours ago